Current Neuropharmacology
Title:Meet Our Editorial Board Member
Volume: 15 Issue: 4
Author(s): Cristine Alves da Costa*
Affiliation:
- Institut de Pharmacologie Moléculaire et Cellulaire UMR7275 CNRS/UNSA Laboratory of Excellence DistALZ 660 route des Lucioles, 06560 Sophia-Antipolis, Valbonne,France
Export Options
About this article
Cite this article as:
Costa Alves da Cristine*, Meet Our Editorial Board Member, Current Neuropharmacology 2017; 15 (4) . https://dx.doi.org/10.2174/1570159X1504170412205854
DOI https://dx.doi.org/10.2174/1570159X1504170412205854 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
13
2
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Comparative Genomic Hybridization: A Valuable Tool for Genome-Scale Analysis of Rodent Cancer Models
Current Genomics Biological Modulation by Lectins and Their Ligands in Tumor Progression and Metastasis
Anti-Cancer Agents in Medicinal Chemistry Towards Human on a Chip: Recent Progress and Future Perspective
Micro and Nanosystems HSP27: Mechanisms of Cellular Protection Against Neuronal Injury
Current Molecular Medicine Mitochondrial Drug Targets in Cell Death and Cancer
Current Pharmaceutical Design Targeting the Nucleus: An Overview of Auger-Electron Radionuclide Therapy
Current Drug Discovery Technologies In Vitro Models of the Blood-Brain Barrier: When to Use Which?
Current Medicinal Chemistry - Central Nervous System Agents Human Cytomegalovirus US28: A Functionally Selective Chemokine Binding Receptor
Infectious Disorders - Drug Targets Cell Penetrating Peptides for Tumor Targeting
Current Pharmaceutical Biotechnology New Molecular Targets in the Treatment of NSCLC
Current Pharmaceutical Design Telomere Maintenance Mechanisms in Cancer: Clinical Implications
Current Pharmaceutical Design Targeted Delivery of Anti-Inflammatory Agents to Tumors
Current Pharmaceutical Design Re-Examining the Need for Tissue Diagnosis in Pediatric Diffuse Intrinsic Pontine Gliomas: A Review
Current Neuropharmacology Tapasin and Human Leukocyte Antigen Class I Dysregulation Correlates with Survival in Glioblastoma Multiforme
Anti-Cancer Agents in Medicinal Chemistry Remyelination in Multiple Sclerosis: The Therapeutic Potential of Neural and Mesenchymal Stem/Progenitor Cells
Current Signal Transduction Therapy Ion Transporters in Brain Tumors
Current Medicinal Chemistry Nanotheranostics in Evidence Based Personalized Medicine
Current Drug Targets Passive and Active Tumour Targeting with Nanocarriers
Current Drug Discovery Technologies Withdrawal Notice: Role, Significance and Association of microRNA-10a/b in Physiology of Cancer
MicroRNA A Novel Marine Drug, SZ–685C, Induces Apoptosis of MMQ Pituitary Tumor Cells by Downregulating miR–200c
Current Medicinal Chemistry